Related Experiment Video

Updated: Jan 29, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

3.2K

Stem Cell-Derived Beta-Cell Therapies: Encapsulation Advances and Immunological Hurdles in Diabetes Treatment

Sana Waris1, Hamna Hameetha Begam1, Manyam Praveen Kumar1

  • 1Research Department, Royal College of Surgeons in Ireland-Bahrain, Adliya 15503, Bahrain.

Cells
|January 28, 2026
PubMed

Insights

Induced pluripotent stem cells offer a promising solution for diabetes treatment by generating insulin-producing cells. This review explores encapsulation and transplantation methods, addressing challenges like immune rejection for future clinical trials.

Area of Science:

  • Endocrinology and Regenerative Medicine
  • Stem Cell Biology
  • Diabetes Research

Background:

  • Diabetes mellitus is characterized by insulin secretion abnormalities.
  • Current treatments include exogenous insulin, with limitations.
  • Stem cell therapy presents a potential curative approach for chronic diseases.

Purpose of the Study:

  • To review the use of induced pluripotent stem cells (iPSCs) for beta-cell generation.
  • To evaluate encapsulation technologies and transplantation sites for iPSC-derived cells.
  • To discuss challenges and risks for human clinical trials in diabetes treatment.

Main Methods:

  • Focus on iPSC-derived beta-cells as an alternative to organ transplantation.
  • Evaluation of current encapsulation techniques to protect transplanted cells.
  • Assessment of various transplantation sites for efficacy and safety.

Main Results:

  • iPSCs provide a sustainable source for insulin-producing beta-cells, addressing organ scarcity.
  • Encapsulation technologies aim to prevent immune rejection of grafts.
  • Animal models demonstrate potential for iPSC-based therapies, but challenges remain.

Conclusions:

  • iPSC-derived beta-cells hold significant promise for diabetes mellitus treatment.
  • Advances in encapsulation and transplantation are crucial for clinical success.
  • Further research is needed to overcome immune rejection and ensure safety in human trials.
Keywords:
encapsulationimmunologicalpancreatic beta-cellsstem cell-derived beta-cells

More Related Videos

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

14.0K
Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model08:06

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

11.8K

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K